Condrosulf 400, compresse - 180 Tablette(n) Swissmedic Key 51610040 Registration Holder IBSA Institut Biochimique SA Name Condrosulf 400, compresse Date of registration 31.10.1991 Introduction of Sequence 24.11.1994 ATC-Classification Chondroitin Sulfate (M01AX25) Revision date 31.10.2005 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.10.60. Show package size 180 Tablette(n) Index Therapeuticus (Swissmedic) 07.10.60. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 50.37 Limitation No Deductible 10 % Consumer price 71.20 Feedback FB GTIN 7680516100406 Medication Code Biotechnologika Pharmacode 1648335 Disponibility
Composition chondroitini sulfas natricus 400 mg, magnesii stearas, pro compresso corresp. natrium 36.6 mg. Teilbarkeit Teilbar Nein Auflösbar oder suspendierbar Nein Zermörsebar Nein Öffnen von Kapseln Nein Bemerkungen / Alternativen Es handelt sich um Weichkapseln Quellen Rinaldo Rossi, IBSA
th_part Galenic Form Tablets Active Agent Dose Chondroitine Sodium Sulfate 400 mg
BAG: Active Agent Dose Chondroitine Sodium Sulfate 400 mg
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
